Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881608 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Menses Induction in Women Administered Proellex
A Phase 1 study, sponsored by Repros Therapeutics.
- Terminated
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT00881608: Clinical Trial Phase 1 study, sponsored by Repros Therapeutics.
NCT00881608 is a Phase 1 study that was terminated before completion, run by Repros Therapeutics. The registered enrollment target is 11 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881608, a Phase 1 study, was terminated before completion, sponsored by Repros Therapeutics.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able induce menstruation.
Interventions
- DRUG Placebo
- DRUG Proellex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Why NCT00881608 stopped before completion
NCT00881608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00881608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00881608 about?
NCT00881608 is a clinical study titled "Study to Evaluate Menses Induction in Women Administered Proellex". The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able induce menstruation.
What is the current status of trial NCT00881608?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2009-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00881608?
The interventions under investigation include: Placebo (DRUG), Proellex (DRUG).
Who is sponsoring clinical trial NCT00881608?
This trial is sponsored by Repros Therapeutics, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00881608's enrollment target sits among peer trials
11 1911th of 2000 higher than 88 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia